Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, shared on X:
“Just published in Critical Reviews in Oncology Hematology (CROH).
We confirms the benefit of perioperative strategies in MIBC.
Huge thanks to all co-authors, especially Veronica Mollica for the brilliant idea!”
Title: Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials.
Authors: Veronica Mollica, Matteo Rosellini, Patrizia Giannatempo, Shilpa Gupta, Enrique Grande, Alessandro Rizzo, Costantino Ricci, Pietro Piazza, Roberto Contieri, Arrigo Cattabriga, Riccardo Schiavina, Matteo Santoni, Francesco Massari
Shilpa Gupta, Professor, Staff, Hematology and Oncology at Cleveland Clinic, added:
“Congrats Veronica Mollica, Francesco Massari on this excellent effort!
Glad to be a part of it will such a great team!
Seeing the new data ESMO will help provide further insights!”
You can also read: Advanced Bladder Cancer: How Is First-Line Treatment Changing?
